2010
DOI: 10.1586/ers.09.70
|View full text |Cite
|
Sign up to set email alerts
|

Omalizumab for childhood asthma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 13 publications
0
1
0
Order By: Relevance
“…So far there is no evidence that this therapy modifies long-term outcomes in the same way as allergen immunotherapy. It has also been employed, with benefit, in allergic rhinitis, severe eczema, persistent urticaria, and as an adjunct to allergen immunotherapy, however its high costs preclude use other than in the most severe forms of allergic disease [52].…”
Section: New Approaches To Management Of Allergic Airway Diseasesmentioning
confidence: 99%
“…So far there is no evidence that this therapy modifies long-term outcomes in the same way as allergen immunotherapy. It has also been employed, with benefit, in allergic rhinitis, severe eczema, persistent urticaria, and as an adjunct to allergen immunotherapy, however its high costs preclude use other than in the most severe forms of allergic disease [52].…”
Section: New Approaches To Management Of Allergic Airway Diseasesmentioning
confidence: 99%